MedTrace Logo

Safety and Efficacy of the Sore Throat Lozenges to Treat Acute Sore Throats

NCT04139681 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2021-08-05

No results posted yet for this study

Summary

Aim of this study is to investigate safety and efficacy of A. Vogel Sore throat lozenges for the treatment of of acute sore throats

Conditions

  • Tonsillopharyngitis
  • Respiratory Tract Infection Viral

Interventions

DRUG

A. Vogels Sore Throat lozenges

5 times 1 A. Vogels sore throat lozenges daily for 4 days

Sponsors & Collaborators

  • A. Vogel AG

    lead INDUSTRY

Principal Investigators

  • Alexandar Buchkov, Dr. med. · Diagnostics and Consultation Center Convex

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-12
Primary Completion
2019-04-26
Completion
2020-03-15

Countries

  • Bulgaria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04139681 on ClinicalTrials.gov